当前位置:首页 - 行情中心 - 合合信息(688615) - 财务分析 - 利润表

合合信息

(688615)

  

流通市值:0.00万  总市值:0.00万
流通股本:0.00万   总股本:0.00万

利润表

报告期2024-06-302023-12-312023-06-302022-12-31
公司类型通用通用通用通用
一、营业总收入688,182,152.221,186,523,789.83564,786,953.13988,461,813.1
营业收入688,182,152.221,186,523,789.83564,786,953.13988,461,813.1
二、营业总成本491,922,204.21921,122,266.4406,123,636.71747,365,272.67
营业成本104,048,939.31186,832,623.1588,045,562.1161,151,374.52
税金及附加5,087,206.267,319,766.453,053,341.925,402,533.72
销售费用183,533,472.26335,046,245.16142,901,958.68268,782,775.55
管理费用34,205,782.3376,024,910.6731,292,927.6961,029,555.35
研发费用168,662,431.28323,376,708.71149,399,772.17279,901,583.58
财务费用-3,615,627.23-7,477,987.74-8,569,925.85-28,902,550.05
其中:利息费用1,424,472.193,005,887.191,435,019.68460,711.55
其中:利息收入4,762,315.7910,089,020.545,405,030.837,315,349.28
加:公允价值变动收益11,889,804.7120,025,021.937,777,206.292,645,764.9
加:投资收益1,276,941.291,253,651.46783,852.741,120,936.47
资产处置收益--1,768.84--
资产减值损失(新)-111,974.67-6,919.591,129.23-28,488.24
信用减值损失(新)-581,366.94-2,919,482.41-1,439,915.61-2,232,447.86
其他收益27,084,062.1439,116,226.8719,552,003.2737,630,994.42
营业利润平衡项目0000
四、营业利润235,817,414.54322,868,252.85185,337,592.34280,233,300.12
加:营业外收入233,624.76223,205.6875,147.79101,154.22
减:营业外支出12,612.17981,735.42697,694.14797,628.97
利润总额平衡项目0000
五、利润总额236,038,427.13322,109,723.11184,715,045.99279,536,825.37
减:所得税费用15,291,614.71-1,071,267.6-2,113,485.42-4,180,906.1
六、净利润220,746,812.42323,180,990.71186,828,531.41283,717,731.47
持续经营净利润220,746,812.42323,180,990.71186,828,531.41283,717,731.47
归属于母公司股东的净利润220,746,803.7323,181,252.94186,828,520.4283,720,343.95
少数股东损益8.72-262.2311.01-2,612.48
(一)基本每股收益2.944.312.493.78
(二)稀释每股收益2.944.312.493.78
八、其他综合收益-685,341.2-973,732.33-811,653.11,133,439.16
归属于母公司股东的其他综合收益-685,341.2-973,732.33-811,653.11,133,439.16
九、综合收益总额220,061,471.22322,207,258.38186,016,878.31284,851,170.63
归属于母公司股东的综合收益总额220,061,462.5322,207,520.61186,016,867.3284,853,783.11
归属于少数股东的综合收益总额8.72-262.2311.01-2,612.48
公告日期2024-09-052024-09-052024-09-052023-07-28
审计意见(境内)标准无保留意见标准无保留意见
TOP↑